HSPA5 and nonpapillary renal cell carcinoma: In conclusion, miR‐30c‐5p‐HSPA5 signalling pathway may be correlated with the progression of ccRCC, which indicates that urinary exosomal miR‐30c‐5p may act as a specific and sensitive biomarker for diagnosing and monitoring the progression of ccRCC.